Pricing Log in Create free account

Beta Bionics, Inc. (BBNX) vs CeriBell, Inc. (CBLL)

Beta Bionics, Inc. and CeriBell, Inc. are both Medical Devices companies. CeriBell, Inc. is the larger, with a market value of $1.1B against $933.8M — 1.1× the size. Beta Bionics, Inc. grew revenue faster over the last twelve months: 52.5% against 31.7%. Beta Bionics, Inc. has the higher net margin (−61.3% vs −64.7%) and the higher return on invested capital (−68.5% vs −229.8%). Across the 17 metrics below, Beta Bionics, Inc. leads on 10 and CeriBell, Inc. on 7.

Valuation

Metric BBNX CBLL Medical Devices median
P/E n/m n/m 23.22
P/S 6.12 9.34 2.34
P/B 2.84 7.42 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 4.60 8.27 2.24
Earnings yield (10.09%) (7.03%) (10.09%)
Free cash flow yield (46.43%) (5.89%) (8.47%)

Profitability

Metric BBNX CBLL Medical Devices median
Gross margin 58.31% 88.90% 56.01%
Operating margin (69.75%) (68.62%) (15.03%)
Net margin (61.32%) (64.73%) (20.40%)
Free cash flow margin (284.13%) (55.02%) (7.24%)
Return on equity (26.16%) (43.93%) (15.32%)
Return on assets (23.45%) (35.29%) (19.72%)
Return on invested capital (68.47%) (229.76%) (10.33%)

Growth

Metric BBNX CBLL Medical Devices median
Revenue growth (TTM) 52.54% 31.70% 8.80%
EPS growth (last fiscal year) 78.95% 56.93% 29.03%
Revenue growth, 5-year CAGR — — 15.47%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric BBNX CBLL Medical Devices median
Debt to equity 0.00 0.16 0.07
Current ratio 8.88 9.18 2.50
Net debt to EBITDA 3.19 2.38 0.49

Dividend

Metric BBNX CBLL Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric BBNX CBLL Medical Devices median
Market cap 933.81m 1.06b 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack